Comparison of the clinical effectiveness of the two different doses of Meropenem in pneumonia
Phase 3
Recruiting
- Conditions
- Bacterial pneumonia.Bacterial pneumonia, not elsewhere classified
- Registration Number
- IRCT20100107003014N19
- Lead Sponsor
- Sari University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Critically ill patients admitted to the intensive care unit
Patients with hospital acquired or ventilator associated pneumonia
Indication to receive Meropenem
between 18 and 70 years old
Exclusion Criteria
Pregnant or breastfeeding women
Acute or chronic renal failure
Epilepsy or history of siezure
CNS infection
Immune-compromised or using immunomodulator agents
Known allergy to carbapenems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical success. Timepoint: 7 days after intervention. Method of measurement: Collecting data forum.
- Secondary Outcome Measures
Name Time Method All-cause mortality. Timepoint: 7, 14 and 28 days after intervention. Method of measurement: Data collecting form.;Clinical success with modification. Timepoint: 7 and 14 days after intervention. Method of measurement: Data collecting form.;Time to weaning. Timepoint: 28 days. Method of measurement: Data collecting form.;Time to intensive care unit discharge. Timepoint: 28 days. Method of measurement: Data collecting form.;Time to hospital discharge. Timepoint: 28 days. Method of measurement: Data collecting form.